EUCTR2015-000914-23-IT进行中（未招募）1 期
Cardiac toxicity prevention in non-metastatic breast cancer patients treated with anthracycline-based chemotherapy: a randomized, placebo controlled, phase 3 trial - SAFE trial. - SAFE2014
DIPARTIMENTO DI SCIENZE BIOMEDICHE SPERIMENTALI E CLINICHE, UNIVERSITà DI FIRENZE0 个研究点目标入组 480 人开始时间: 2020年11月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Non metastatic Histologically confirmed primary breast cancer
- •Scheduled to receive neoadjuvant or adjuvant chemotherapy with or without anti Her 2 therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 480
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 200
排除标准
- •Pregnant or lactating women
- •Treatment with ACE inhibitors or beta blockers at diagnosis
- •History of Grade >2 symptimatic congestive heart failure, previous myocardial infarction, significative symptoms relating to LVEF disfunction, valvular disfunction, cardiac arrythmias > G3
研究者
相似试验
进行中（未招募）
1 期
Can the heart drug enalapril prevent heart damage in patients with newly diagnosed breast cancer and lymphoma receiving chemotherapy?Prevention of cardiotoxicityMedDRA version: 20.0Level: PTClassification code 10048610Term: CardiotoxicitySystem Organ Class: 10007541 - Cardiac disordersEUCTR2017-001094-16-GBSouth Tees NHS Foundation Trust170
已完成
不适用
Detection of chemotherapy induced cardiac TOXicity in breast cancer studyPatients with breast cancer undergoing anthracycline chemotherapyJPRN-UMIN000014741Department of Cardiovascular Medicine, Kyoto University Hospital100
进行中（未招募）
不适用
Comparison between 2 different hydration strategies (saline solution vs carbonati) for the prevention of contrast induced nephropaty in patients at risk for heart failure undergoing coronary angiography or interventioPatients undergoing coronary angiography or angioplastyMedDRA version: 14.1Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-003611-37-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA' DI NOVARA240
进行中（未招募）
不适用
PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecrosiS in elective coronary angioplasty. A prospective double-blind randomized trial (PREVENT ICARUS) trial - PREVENT-ICARUSElective coronary angioplastyMedDRA version: 9.1Level: SOCClassification code 10047065EUCTR2009-013681-92-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
进行中（未招募）
1 期
Prevention of the reperfusion myocardical damage in patients with acute myocardial infarct submitted to primary PCI through infusion of 'glutatione sale sodico' ev.acute myocardial infarctEUCTR2014-004486-25-ITniversity Hospital Policlinico Umberto I90